Diabetes has always been a matter of concern to health experts as well as the community due to the increasing number of patients with diabetes and the severe consequences it may cause. Many attempts have been made to discover new treatment options for diabetes, and herbal medicines are currently considered to have great potential. This study was conducted to evaluate the effect ofCamellia flavaflower extract on the degeneration of the islets of Langerhans and insulin resistance in an alloxan-induced hyperglycemia model in Swiss albino mice. Hyperglycemic conditions were induced by alloxan (55 mg/kg, i.v.). The animals were then treated with glibenclamide (10 mg/kg, p.o.) and flower extract at doses of 1.09 and 2.19 g/kg, p.o. The results showed that the blood glucose, AUC, HbA1c, and HOMA-IR levels of two groups of mice receiving flower extract were considerably lower than those of the hyperglycemic untreated group (p < 0.05). The body weights of these two groups were also lower than the untreated group on the last day of the experiment, though the differences were not significant (p > 0.05). However, this was not observed when assessing insulin levels as well as relative organ weights. In biochemical tests, creatinine and AST and ALT concentrations were evaluated. There was no significant variation in creatinine and AST concentrations between the five experimental groups, whereas mice treated with glibenclamide and flower extract at both doses showed a remarkable decline in ALT concentration (p < 0.05). The hepatic histomicrographs were consistent with ALT results, while the H&E staining of kidneys showed no difference between groups. Histomicrographs of the pancreas revealed that the treatment groups using glibenclamide and flower extract had larger islets of Langerhans than those of the alloxan-treated group. Based on these results, this study demonstrated thatCamellia flavaflower extract exerted several beneficial effects, including blood sugar level reduction, weight loss promotion, and organ protection, hence making it a new potential herbal medication for the management of diabetes.
Golden camellia, a group of herbal materials belonging to the Theaceae family, was widely distributed in Asian countries, particularly Vietnam and southern China. Numerous pharmacological effects of various golden camellia species have been reported in reputable databases such as PubMed and Google Scholar. These effects included anti-tumor, lipid-lowering, anxiolytic, antidepressant, neuroprotective, antioxidant, antibacterial, and anti-inflammatory properties. Furthermore, toxicity studies on golden camellia species have demonstrated their safety for use. Our systematic review provides a comprehensive understanding of the pharmacological effects and safety of various golden camellia species, aiming to provide reliable evidence for the clinical use of this herbal material.
Camellia hakodae Ninh flowers are an endemic Vietnamese species with limited phytochemical and biological characterization. This study aimed to characterize the phytochemical profile and evaluate antioxidant and anti-inflammatory activities of the total flower extract. Ultrasonic-assisted extraction (UAE) and maceration with methanol and ethanol at different concentrations were carried out to evaluate the efficiency of extracting total phenolic content (TPC) and total flavonoid content (TFC), quantified by colorimetric assays, along with the antioxidant and anti-inflammatory activities of the resulting extracts. The highest TPC (94.9 ± 4.5 mg GAE/g) and TFC (3.1 ± 0.2 mg QE/g) were obtained using UAE with 70% methanol, while maceration with 70% ethanol showed comparable TPC values. The optimized extract exhibited strong antioxidant activity with an IC50 of 29.06 µg/mL, close to that of ascorbic acid (28.16 µg/mL) and significant anti-inflammatory activity in the proteinase inhibition assay (IC50 = 2.72 mg/mL) compared to acetylsalicylic acid (IC50 = 3.16 mg/mL). GC-MS and LC-QTOF-MS/MS analyses revealed diverse metabolites, including phenolic acids, flavonoids, fatty acids, terpenoids, and nitrogen-containing compounds, with representative constituents, such as quinic acid, catechins, flavonol glycosides, and loliolide, providing strong chemical evidence for the observed bioactivities. This integrated study demonstrates that C. hakodae flower is a rich source of multifunctional bioactive compounds and highlights its strong potential for applications in nutraceuticals, functional foods, and cosmeceuticals.